A device for taking repeated biopsies of glioblastoma tumors
Tumor Monorail Device for Serial Glioblastoma Biopsy
This study is testing a new device called the Tumor Monorail that helps doctors take safe and precise samples from glioblastoma tumors, making it easier to track how the tumor is changing and how well treatments are working, ultimately aiming to improve care for patients like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Exvade Bioscience, INC. NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11174633 on NIH RePORTER |
What this research studies
This research focuses on developing the Tumor Monorail, a device designed to enable safe and accurate serial biopsies of glioblastoma tumors. By providing real-time access to tumor material, the device aims to improve the monitoring of tumor progression and treatment response, which is crucial for adjusting therapies to enhance patient outcomes. The approach involves leveraging established materials and designs that have been proven safe in clinical settings, ensuring reliability and biocompatibility. This innovative method seeks to address the limitations of current biopsy techniques and imaging methods that often fail to provide comprehensive insights into tumor behavior.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who require ongoing monitoring of their tumor status.
Not a fit: Patients with non-glioblastoma brain tumors or those who are not undergoing treatment for glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the management of glioblastoma by allowing for timely adjustments to treatment based on accurate tumor monitoring.
How similar studies have performed: While the concept of serial biopsies is not entirely novel, the specific application of the Tumor Monorail device represents a new approach that has not been extensively tested in clinical settings.
Where this research is happening
Atlanta, United States
- Exvade Bioscience, INC. — Atlanta, United States (Active)
Researchers
- Principal investigator: Meehan, Sean — Exvade Bioscience, INC.
- Study coordinator: Meehan, Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.